Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q4 2024 ▲▼ | Q1 2025 ▲▼ | Change ▲▼ | Q4 2024 ▲▼ | Q1 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Actuate Therapeutics Inc | 9,893,651 | 9,893,651 | 0 | $78.75M | $66.98M | 84.59% | -$11.77M |
| Lantern Pharma Inc.(LTRN) | 1,207,709 | 1,207,709 | 0 | $3.85M | $4.28M | 5.40% | +$422.7K |
| Rein Therapeutics Inc.(RNTX) | 1,690,751 | 1,690,751 | 0 | $3.89M | $2.99M | 3.78% | -$896.1K |
| Cognition Therapeutics, Inc.(CGTX) | 6,000,000 | 6,000,000 | 0 | $4.21M | $2.52M | 3.19% | -$1.68M |
| In8bio Inc | 8,600,001 | 8,600,001 | 0 | $2.21M | $1.43M | 1.80% | -$784.3K |
| Opus Genetics, Inc.(IRD) | 995,249 | 995,249 | 0 | $1.18M | $977.1K | 1.23% | -$207.2K |